We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$50.2M
Cap. Flow %
22.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Miscellaneous 7.53%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
376
Alibaba
BABA
$281B
-7,000
Closed -$1.25M
BKU icon
377
Bankunited
BKU
$3.3B
-13,633
Closed -$520K
BMY icon
378
CALL
Bristol-Myers Squibb
BMY
$136B
-412
Closed -$48.1K
BMY icon
379
Bristol-Myers Squibb
BMY
$136B
-29,793
Closed -$1.34M
C icon
380
CALL
Citigroup
C
$231B
-151
Closed -$102K
CCCC icon
381
CALL
C4 Therapeutics
CCCC
$463M
-325
Closed -$3.25K
CFLT
382
DELISTED
Confluent
CFLT
-50,000
Closed -$990K
CHTR icon
383
Charter Communications
CHTR
$18.1B
-2,341
Closed -$644K
COGT icon
384
CALL
Cogent Biosciences
COGT
$6.03B
-460
Closed -$133K
CPRX
385
DELISTED
Catalyst Pharmaceutical
CPRX
-11,441
Closed -$225K
CRH icon
386
CRH
CRH
$62.7B
-2,926
Closed -$351K
CTMX icon
387
CytomX Therapeutics
CTMX
$808M
-42,645
Closed -$136K
DGX icon
388
Quest Diagnostics
DGX
$26.2B
-12,081
Closed -$2.3M
DNN icon
389
Denison Mines
DNN
$3.1B
-112,549
Closed -$310K
EVH icon
390
Evolent Health
EVH
$488M
-77,638
Closed -$657K
FOLD
391
CALL
DELISTED
Amicus Therapeutics
FOLD
-303
Closed -$16.7K
FTAI icon
392
FTAI Aviation
FTAI
$20.2B
-2,000
Closed -$334K
FUTU icon
393
Futu Holdings
FUTU
$17.1B
-2,272
Closed -$395K
GLD icon
394
CALL
SPDR Gold Trust
GLD
$149B
-42
Closed -$34.4K
HBM icon
395
Hudbay
HBM
$12.2B
-67,754
Closed -$1.03M
HCA icon
396
HCA Healthcare
HCA
$87.7B
-2,353
Closed -$1M
HCC icon
397
Warrior Met Coal
HCC
$5.52B
-3,716
Closed -$236K
HOOD icon
398
CALL
Robinhood
HOOD
$110B
-157
Closed -$188K
HRMY icon
399
CALL
Harmony Biosciences
HRMY
$2.46B
-345
Closed -$3
HRMY icon
400
PUT
Harmony Biosciences
HRMY
$2.46B
-115
Closed -$143K

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $50.2M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.